Qvanteq AG develops novel biofunctional surfaces to address and overcome the clinical adverse effects of today’s vascular stents.

Location
Canton
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2009
  • Number of employees in Switzerland
    1-9
Key business

You may also be interested in